Impact of Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- coagulation
研究概览
简要总结
The study focus on the impact of estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in women undertaking assisted reproductive technology treatment (ART).
详细描述
The aim is to investigate whether the coagulation is activated in women undergoing estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in assisted reproductive technology treatment (ART). An activation of the coagulation might induce an increased thromboembolic risk in these women. Thus, the present study may lead to improvement of the current treatment protocol for women receiving AC-FET and ultimately prevent thromboembolic complications for woman in fertility treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women receiving FET with or without estrogen/progesterone substitution
排除标准
- •Known bleeding disorder
- •Indication for thromboprophylaxis during ART treatment
- •Treatment with anti-platelet medication including non-steroid-anti-inflammatory drugs (NSAIDs) within the last week
- •Donor recipients
结局指标
主要结局
coagulation
时间窗: 1 year
Primary and secondary hemostasis parameters
次要结局
未报告次要终点
研究者
Ulla Breth Knudsen
Professor
Horsens Hospital